Global Small Molecule Drug CDMO Market Research Report 2024(Status and Outlook)
Report Overview
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report provides a deep insight into the global Small Molecule Drug CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Small Molecule Drug CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Small Molecule Drug CDMO market in any manner.
Global Small Molecule Drug CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Market Segmentation (by Type)
FDF CDMO
Packaging CDMO
Clinical CDMO
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Molecule Drug CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
This report provides a deep insight into the global Small Molecule Drug CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Small Molecule Drug CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Small Molecule Drug CDMO market in any manner.
Global Small Molecule Drug CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Market Segmentation (by Type)
FDF CDMO
Packaging CDMO
Clinical CDMO
Market Segmentation (by Application)
Pharmaceutical Company
Biotechnology Company
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Small Molecule Drug CDMO Market
- Overview of the regional outlook of the Small Molecule Drug CDMO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Molecule Drug CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Small Molecule Drug CDMO
1.2 Key Market Segments
1.2.1 Small Molecule Drug CDMO Segment by Type
1.2.2 Small Molecule Drug CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL MOLECULE DRUG CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Molecule Drug CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Small Molecule Drug CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL MOLECULE DRUG CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Small Molecule Drug CDMO Sales by Manufacturers (2019-2024)
3.2 Global Small Molecule Drug CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Small Molecule Drug CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Small Molecule Drug CDMO Sales Sites, Area Served, Product Type
3.6 Small Molecule Drug CDMO Market Competitive Situation and Trends
3.6.1 Small Molecule Drug CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Small Molecule Drug CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE DRUG CDMO INDUSTRY CHAIN ANALYSIS
4.1 Small Molecule Drug CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE DRUG CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Drug CDMO Sales Market Share by Type (2019-2024)
6.3 Global Small Molecule Drug CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Small Molecule Drug CDMO Price by Type (2019-2024)
7 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Drug CDMO Market Sales by Application (2019-2024)
7.3 Global Small Molecule Drug CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Small Molecule Drug CDMO Sales Growth Rate by Application (2019-2024)
8 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY REGION
8.1 Global Small Molecule Drug CDMO Sales by Region
8.1.1 Global Small Molecule Drug CDMO Sales by Region
8.1.2 Global Small Molecule Drug CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Small Molecule Drug CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Small Molecule Drug CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Small Molecule Drug CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Small Molecule Drug CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Small Molecule Drug CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza
9.1.1 Lonza Small Molecule Drug CDMO Basic Information
9.1.2 Lonza Small Molecule Drug CDMO Product Overview
9.1.3 Lonza Small Molecule Drug CDMO Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Small Molecule Drug CDMO SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 Catalent
9.2.1 Catalent Small Molecule Drug CDMO Basic Information
9.2.2 Catalent Small Molecule Drug CDMO Product Overview
9.2.3 Catalent Small Molecule Drug CDMO Product Market Performance
9.2.4 Catalent Business Overview
9.2.5 Catalent Small Molecule Drug CDMO SWOT Analysis
9.2.6 Catalent Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Small Molecule Drug CDMO Basic Information
9.3.2 Thermo Fisher Scientific Small Molecule Drug CDMO Product Overview
9.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Product Market Performance
9.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Samsung Biologics
9.4.1 Samsung Biologics Small Molecule Drug CDMO Basic Information
9.4.2 Samsung Biologics Small Molecule Drug CDMO Product Overview
9.4.3 Samsung Biologics Small Molecule Drug CDMO Product Market Performance
9.4.4 Samsung Biologics Business Overview
9.4.5 Samsung Biologics Recent Developments
9.5 Fareva
9.5.1 Fareva Small Molecule Drug CDMO Basic Information
9.5.2 Fareva Small Molecule Drug CDMO Product Overview
9.5.3 Fareva Small Molecule Drug CDMO Product Market Performance
9.5.4 Fareva Business Overview
9.5.5 Fareva Recent Developments
9.6 WuXi AppTech
9.6.1 WuXi AppTech Small Molecule Drug CDMO Basic Information
9.6.2 WuXi AppTech Small Molecule Drug CDMO Product Overview
9.6.3 WuXi AppTech Small Molecule Drug CDMO Product Market Performance
9.6.4 WuXi AppTech Business Overview
9.6.5 WuXi AppTech Recent Developments
9.7 WuXi Biologics
9.7.1 WuXi Biologics Small Molecule Drug CDMO Basic Information
9.7.2 WuXi Biologics Small Molecule Drug CDMO Product Overview
9.7.3 WuXi Biologics Small Molecule Drug CDMO Product Market Performance
9.7.4 WuXi Biologics Business Overview
9.7.5 WuXi Biologics Recent Developments
9.8 Siegfried
9.8.1 Siegfried Small Molecule Drug CDMO Basic Information
9.8.2 Siegfried Small Molecule Drug CDMO Product Overview
9.8.3 Siegfried Small Molecule Drug CDMO Product Market Performance
9.8.4 Siegfried Business Overview
9.8.5 Siegfried Recent Developments
9.9 FUJIFILM Diosynth Biotechnologies
9.9.1 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Basic Information
9.9.2 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Overview
9.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Market Performance
9.9.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.10 Asymchem
9.10.1 Asymchem Small Molecule Drug CDMO Basic Information
9.10.2 Asymchem Small Molecule Drug CDMO Product Overview
9.10.3 Asymchem Small Molecule Drug CDMO Product Market Performance
9.10.4 Asymchem Business Overview
9.10.5 Asymchem Recent Developments
9.11 Pfizer CentreOne
9.11.1 Pfizer CentreOne Small Molecule Drug CDMO Basic Information
9.11.2 Pfizer CentreOne Small Molecule Drug CDMO Product Overview
9.11.3 Pfizer CentreOne Small Molecule Drug CDMO Product Market Performance
9.11.4 Pfizer CentreOne Business Overview
9.11.5 Pfizer CentreOne Recent Developments
9.12 Delpharm
9.12.1 Delpharm Small Molecule Drug CDMO Basic Information
9.12.2 Delpharm Small Molecule Drug CDMO Product Overview
9.12.3 Delpharm Small Molecule Drug CDMO Product Market Performance
9.12.4 Delpharm Business Overview
9.12.5 Delpharm Recent Developments
9.13 Recipharm
9.13.1 Recipharm Small Molecule Drug CDMO Basic Information
9.13.2 Recipharm Small Molecule Drug CDMO Product Overview
9.13.3 Recipharm Small Molecule Drug CDMO Product Market Performance
9.13.4 Recipharm Business Overview
9.13.5 Recipharm Recent Developments
9.14 AGC Pharma Chemicals
9.14.1 AGC Pharma Chemicals Small Molecule Drug CDMO Basic Information
9.14.2 AGC Pharma Chemicals Small Molecule Drug CDMO Product Overview
9.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Product Market Performance
9.14.4 AGC Pharma Chemicals Business Overview
9.14.5 AGC Pharma Chemicals Recent Developments
9.15 Boehringer Ingelheim
9.15.1 Boehringer Ingelheim Small Molecule Drug CDMO Basic Information
9.15.2 Boehringer Ingelheim Small Molecule Drug CDMO Product Overview
9.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Product Market Performance
9.15.4 Boehringer Ingelheim Business Overview
9.15.5 Boehringer Ingelheim Recent Developments
9.16 Vetter
9.16.1 Vetter Small Molecule Drug CDMO Basic Information
9.16.2 Vetter Small Molecule Drug CDMO Product Overview
9.16.3 Vetter Small Molecule Drug CDMO Product Market Performance
9.16.4 Vetter Business Overview
9.16.5 Vetter Recent Developments
9.17 Curia
9.17.1 Curia Small Molecule Drug CDMO Basic Information
9.17.2 Curia Small Molecule Drug CDMO Product Overview
9.17.3 Curia Small Molecule Drug CDMO Product Market Performance
9.17.4 Curia Business Overview
9.17.5 Curia Recent Developments
9.18 Aenova
9.18.1 Aenova Small Molecule Drug CDMO Basic Information
9.18.2 Aenova Small Molecule Drug CDMO Product Overview
9.18.3 Aenova Small Molecule Drug CDMO Product Market Performance
9.18.4 Aenova Business Overview
9.18.5 Aenova Recent Developments
9.19 Porton
9.19.1 Porton Small Molecule Drug CDMO Basic Information
9.19.2 Porton Small Molecule Drug CDMO Product Overview
9.19.3 Porton Small Molecule Drug CDMO Product Market Performance
9.19.4 Porton Business Overview
9.19.5 Porton Recent Developments
10 SMALL MOLECULE DRUG CDMO MARKET FORECAST BY REGION
10.1 Global Small Molecule Drug CDMO Market Size Forecast
10.2 Global Small Molecule Drug CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Small Molecule Drug CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Small Molecule Drug CDMO Market Size Forecast by Region
10.2.4 South America Small Molecule Drug CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Small Molecule Drug CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Small Molecule Drug CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Small Molecule Drug CDMO by Type (2025-2030)
11.1.2 Global Small Molecule Drug CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Small Molecule Drug CDMO by Type (2025-2030)
11.2 Global Small Molecule Drug CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Small Molecule Drug CDMO Sales (K Units) Forecast by Application
11.2.2 Global Small Molecule Drug CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Small Molecule Drug CDMO
1.2 Key Market Segments
1.2.1 Small Molecule Drug CDMO Segment by Type
1.2.2 Small Molecule Drug CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL MOLECULE DRUG CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Molecule Drug CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Small Molecule Drug CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL MOLECULE DRUG CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Small Molecule Drug CDMO Sales by Manufacturers (2019-2024)
3.2 Global Small Molecule Drug CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Small Molecule Drug CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Small Molecule Drug CDMO Sales Sites, Area Served, Product Type
3.6 Small Molecule Drug CDMO Market Competitive Situation and Trends
3.6.1 Small Molecule Drug CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Small Molecule Drug CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE DRUG CDMO INDUSTRY CHAIN ANALYSIS
4.1 Small Molecule Drug CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE DRUG CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Drug CDMO Sales Market Share by Type (2019-2024)
6.3 Global Small Molecule Drug CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Small Molecule Drug CDMO Price by Type (2019-2024)
7 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Drug CDMO Market Sales by Application (2019-2024)
7.3 Global Small Molecule Drug CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Small Molecule Drug CDMO Sales Growth Rate by Application (2019-2024)
8 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY REGION
8.1 Global Small Molecule Drug CDMO Sales by Region
8.1.1 Global Small Molecule Drug CDMO Sales by Region
8.1.2 Global Small Molecule Drug CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Small Molecule Drug CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Small Molecule Drug CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Small Molecule Drug CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Small Molecule Drug CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Small Molecule Drug CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza
9.1.1 Lonza Small Molecule Drug CDMO Basic Information
9.1.2 Lonza Small Molecule Drug CDMO Product Overview
9.1.3 Lonza Small Molecule Drug CDMO Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Small Molecule Drug CDMO SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 Catalent
9.2.1 Catalent Small Molecule Drug CDMO Basic Information
9.2.2 Catalent Small Molecule Drug CDMO Product Overview
9.2.3 Catalent Small Molecule Drug CDMO Product Market Performance
9.2.4 Catalent Business Overview
9.2.5 Catalent Small Molecule Drug CDMO SWOT Analysis
9.2.6 Catalent Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Small Molecule Drug CDMO Basic Information
9.3.2 Thermo Fisher Scientific Small Molecule Drug CDMO Product Overview
9.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Product Market Performance
9.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Samsung Biologics
9.4.1 Samsung Biologics Small Molecule Drug CDMO Basic Information
9.4.2 Samsung Biologics Small Molecule Drug CDMO Product Overview
9.4.3 Samsung Biologics Small Molecule Drug CDMO Product Market Performance
9.4.4 Samsung Biologics Business Overview
9.4.5 Samsung Biologics Recent Developments
9.5 Fareva
9.5.1 Fareva Small Molecule Drug CDMO Basic Information
9.5.2 Fareva Small Molecule Drug CDMO Product Overview
9.5.3 Fareva Small Molecule Drug CDMO Product Market Performance
9.5.4 Fareva Business Overview
9.5.5 Fareva Recent Developments
9.6 WuXi AppTech
9.6.1 WuXi AppTech Small Molecule Drug CDMO Basic Information
9.6.2 WuXi AppTech Small Molecule Drug CDMO Product Overview
9.6.3 WuXi AppTech Small Molecule Drug CDMO Product Market Performance
9.6.4 WuXi AppTech Business Overview
9.6.5 WuXi AppTech Recent Developments
9.7 WuXi Biologics
9.7.1 WuXi Biologics Small Molecule Drug CDMO Basic Information
9.7.2 WuXi Biologics Small Molecule Drug CDMO Product Overview
9.7.3 WuXi Biologics Small Molecule Drug CDMO Product Market Performance
9.7.4 WuXi Biologics Business Overview
9.7.5 WuXi Biologics Recent Developments
9.8 Siegfried
9.8.1 Siegfried Small Molecule Drug CDMO Basic Information
9.8.2 Siegfried Small Molecule Drug CDMO Product Overview
9.8.3 Siegfried Small Molecule Drug CDMO Product Market Performance
9.8.4 Siegfried Business Overview
9.8.5 Siegfried Recent Developments
9.9 FUJIFILM Diosynth Biotechnologies
9.9.1 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Basic Information
9.9.2 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Overview
9.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Market Performance
9.9.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.10 Asymchem
9.10.1 Asymchem Small Molecule Drug CDMO Basic Information
9.10.2 Asymchem Small Molecule Drug CDMO Product Overview
9.10.3 Asymchem Small Molecule Drug CDMO Product Market Performance
9.10.4 Asymchem Business Overview
9.10.5 Asymchem Recent Developments
9.11 Pfizer CentreOne
9.11.1 Pfizer CentreOne Small Molecule Drug CDMO Basic Information
9.11.2 Pfizer CentreOne Small Molecule Drug CDMO Product Overview
9.11.3 Pfizer CentreOne Small Molecule Drug CDMO Product Market Performance
9.11.4 Pfizer CentreOne Business Overview
9.11.5 Pfizer CentreOne Recent Developments
9.12 Delpharm
9.12.1 Delpharm Small Molecule Drug CDMO Basic Information
9.12.2 Delpharm Small Molecule Drug CDMO Product Overview
9.12.3 Delpharm Small Molecule Drug CDMO Product Market Performance
9.12.4 Delpharm Business Overview
9.12.5 Delpharm Recent Developments
9.13 Recipharm
9.13.1 Recipharm Small Molecule Drug CDMO Basic Information
9.13.2 Recipharm Small Molecule Drug CDMO Product Overview
9.13.3 Recipharm Small Molecule Drug CDMO Product Market Performance
9.13.4 Recipharm Business Overview
9.13.5 Recipharm Recent Developments
9.14 AGC Pharma Chemicals
9.14.1 AGC Pharma Chemicals Small Molecule Drug CDMO Basic Information
9.14.2 AGC Pharma Chemicals Small Molecule Drug CDMO Product Overview
9.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Product Market Performance
9.14.4 AGC Pharma Chemicals Business Overview
9.14.5 AGC Pharma Chemicals Recent Developments
9.15 Boehringer Ingelheim
9.15.1 Boehringer Ingelheim Small Molecule Drug CDMO Basic Information
9.15.2 Boehringer Ingelheim Small Molecule Drug CDMO Product Overview
9.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Product Market Performance
9.15.4 Boehringer Ingelheim Business Overview
9.15.5 Boehringer Ingelheim Recent Developments
9.16 Vetter
9.16.1 Vetter Small Molecule Drug CDMO Basic Information
9.16.2 Vetter Small Molecule Drug CDMO Product Overview
9.16.3 Vetter Small Molecule Drug CDMO Product Market Performance
9.16.4 Vetter Business Overview
9.16.5 Vetter Recent Developments
9.17 Curia
9.17.1 Curia Small Molecule Drug CDMO Basic Information
9.17.2 Curia Small Molecule Drug CDMO Product Overview
9.17.3 Curia Small Molecule Drug CDMO Product Market Performance
9.17.4 Curia Business Overview
9.17.5 Curia Recent Developments
9.18 Aenova
9.18.1 Aenova Small Molecule Drug CDMO Basic Information
9.18.2 Aenova Small Molecule Drug CDMO Product Overview
9.18.3 Aenova Small Molecule Drug CDMO Product Market Performance
9.18.4 Aenova Business Overview
9.18.5 Aenova Recent Developments
9.19 Porton
9.19.1 Porton Small Molecule Drug CDMO Basic Information
9.19.2 Porton Small Molecule Drug CDMO Product Overview
9.19.3 Porton Small Molecule Drug CDMO Product Market Performance
9.19.4 Porton Business Overview
9.19.5 Porton Recent Developments
10 SMALL MOLECULE DRUG CDMO MARKET FORECAST BY REGION
10.1 Global Small Molecule Drug CDMO Market Size Forecast
10.2 Global Small Molecule Drug CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Small Molecule Drug CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Small Molecule Drug CDMO Market Size Forecast by Region
10.2.4 South America Small Molecule Drug CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Small Molecule Drug CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Small Molecule Drug CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Small Molecule Drug CDMO by Type (2025-2030)
11.1.2 Global Small Molecule Drug CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Small Molecule Drug CDMO by Type (2025-2030)
11.2 Global Small Molecule Drug CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Small Molecule Drug CDMO Sales (K Units) Forecast by Application
11.2.2 Global Small Molecule Drug CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Molecule Drug CDMO Market Size Comparison by Region (M USD)
Table 5. Global Small Molecule Drug CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Small Molecule Drug CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Small Molecule Drug CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Small Molecule Drug CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2022)
Table 10. Global Market Small Molecule Drug CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Small Molecule Drug CDMO Sales Sites and Area Served
Table 12. Manufacturers Small Molecule Drug CDMO Product Type
Table 13. Global Small Molecule Drug CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Small Molecule Drug CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Molecule Drug CDMO Market Challenges
Table 22. Global Small Molecule Drug CDMO Sales by Type (K Units)
Table 23. Global Small Molecule Drug CDMO Market Size by Type (M USD)
Table 24. Global Small Molecule Drug CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Small Molecule Drug CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Small Molecule Drug CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Small Molecule Drug CDMO Market Size Share by Type (2019-2024)
Table 28. Global Small Molecule Drug CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Small Molecule Drug CDMO Sales (K Units) by Application
Table 30. Global Small Molecule Drug CDMO Market Size by Application
Table 31. Global Small Molecule Drug CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Small Molecule Drug CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Small Molecule Drug CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Small Molecule Drug CDMO Market Share by Application (2019-2024)
Table 35. Global Small Molecule Drug CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Small Molecule Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Small Molecule Drug CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Small Molecule Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Small Molecule Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Small Molecule Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Small Molecule Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Small Molecule Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Lonza Small Molecule Drug CDMO Basic Information
Table 44. Lonza Small Molecule Drug CDMO Product Overview
Table 45. Lonza Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Small Molecule Drug CDMO SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. Catalent Small Molecule Drug CDMO Basic Information
Table 50. Catalent Small Molecule Drug CDMO Product Overview
Table 51. Catalent Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Catalent Business Overview
Table 53. Catalent Small Molecule Drug CDMO SWOT Analysis
Table 54. Catalent Recent Developments
Table 55. Thermo Fisher Scientific Small Molecule Drug CDMO Basic Information
Table 56. Thermo Fisher Scientific Small Molecule Drug CDMO Product Overview
Table 57. Thermo Fisher Scientific Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Small Molecule Drug CDMO SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Samsung Biologics Small Molecule Drug CDMO Basic Information
Table 62. Samsung Biologics Small Molecule Drug CDMO Product Overview
Table 63. Samsung Biologics Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Samsung Biologics Business Overview
Table 65. Samsung Biologics Recent Developments
Table 66. Fareva Small Molecule Drug CDMO Basic Information
Table 67. Fareva Small Molecule Drug CDMO Product Overview
Table 68. Fareva Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fareva Business Overview
Table 70. Fareva Recent Developments
Table 71. WuXi AppTech Small Molecule Drug CDMO Basic Information
Table 72. WuXi AppTech Small Molecule Drug CDMO Product Overview
Table 73. WuXi AppTech Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. WuXi AppTech Business Overview
Table 75. WuXi AppTech Recent Developments
Table 76. WuXi Biologics Small Molecule Drug CDMO Basic Information
Table 77. WuXi Biologics Small Molecule Drug CDMO Product Overview
Table 78. WuXi Biologics Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. WuXi Biologics Business Overview
Table 80. WuXi Biologics Recent Developments
Table 81. Siegfried Small Molecule Drug CDMO Basic Information
Table 82. Siegfried Small Molecule Drug CDMO Product Overview
Table 83. Siegfried Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Siegfried Business Overview
Table 85. Siegfried Recent Developments
Table 86. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Basic Information
Table 87. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Overview
Table 88. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. FUJIFILM Diosynth Biotechnologies Business Overview
Table 90. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 91. Asymchem Small Molecule Drug CDMO Basic Information
Table 92. Asymchem Small Molecule Drug CDMO Product Overview
Table 93. Asymchem Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Asymchem Business Overview
Table 95. Asymchem Recent Developments
Table 96. Pfizer CentreOne Small Molecule Drug CDMO Basic Information
Table 97. Pfizer CentreOne Small Molecule Drug CDMO Product Overview
Table 98. Pfizer CentreOne Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer CentreOne Business Overview
Table 100. Pfizer CentreOne Recent Developments
Table 101. Delpharm Small Molecule Drug CDMO Basic Information
Table 102. Delpharm Small Molecule Drug CDMO Product Overview
Table 103. Delpharm Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Delpharm Business Overview
Table 105. Delpharm Recent Developments
Table 106. Recipharm Small Molecule Drug CDMO Basic Information
Table 107. Recipharm Small Molecule Drug CDMO Product Overview
Table 108. Recipharm Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Recipharm Business Overview
Table 110. Recipharm Recent Developments
Table 111. AGC Pharma Chemicals Small Molecule Drug CDMO Basic Information
Table 112. AGC Pharma Chemicals Small Molecule Drug CDMO Product Overview
Table 113. AGC Pharma Chemicals Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. AGC Pharma Chemicals Business Overview
Table 115. AGC Pharma Chemicals Recent Developments
Table 116. Boehringer Ingelheim Small Molecule Drug CDMO Basic Information
Table 117. Boehringer Ingelheim Small Molecule Drug CDMO Product Overview
Table 118. Boehringer Ingelheim Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Boehringer Ingelheim Business Overview
Table 120. Boehringer Ingelheim Recent Developments
Table 121. Vetter Small Molecule Drug CDMO Basic Information
Table 122. Vetter Small Molecule Drug CDMO Product Overview
Table 123. Vetter Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Vetter Business Overview
Table 125. Vetter Recent Developments
Table 126. Curia Small Molecule Drug CDMO Basic Information
Table 127. Curia Small Molecule Drug CDMO Product Overview
Table 128. Curia Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Curia Business Overview
Table 130. Curia Recent Developments
Table 131. Aenova Small Molecule Drug CDMO Basic Information
Table 132. Aenova Small Molecule Drug CDMO Product Overview
Table 133. Aenova Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Aenova Business Overview
Table 135. Aenova Recent Developments
Table 136. Porton Small Molecule Drug CDMO Basic Information
Table 137. Porton Small Molecule Drug CDMO Product Overview
Table 138. Porton Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Porton Business Overview
Table 140. Porton Recent Developments
Table 141. Global Small Molecule Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 142. Global Small Molecule Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Small Molecule Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 144. North America Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Small Molecule Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 146. Europe Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Small Molecule Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 148. Asia Pacific Small Molecule Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Small Molecule Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 150. South America Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Small Molecule Drug CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Small Molecule Drug CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 154. Global Small Molecule Drug CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Small Molecule Drug CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 156. Global Small Molecule Drug CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 157. Global Small Molecule Drug CDMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Molecule Drug CDMO Market Size Comparison by Region (M USD)
Table 5. Global Small Molecule Drug CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Small Molecule Drug CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Small Molecule Drug CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Small Molecule Drug CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2022)
Table 10. Global Market Small Molecule Drug CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Small Molecule Drug CDMO Sales Sites and Area Served
Table 12. Manufacturers Small Molecule Drug CDMO Product Type
Table 13. Global Small Molecule Drug CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Small Molecule Drug CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Molecule Drug CDMO Market Challenges
Table 22. Global Small Molecule Drug CDMO Sales by Type (K Units)
Table 23. Global Small Molecule Drug CDMO Market Size by Type (M USD)
Table 24. Global Small Molecule Drug CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Small Molecule Drug CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Small Molecule Drug CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Small Molecule Drug CDMO Market Size Share by Type (2019-2024)
Table 28. Global Small Molecule Drug CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Small Molecule Drug CDMO Sales (K Units) by Application
Table 30. Global Small Molecule Drug CDMO Market Size by Application
Table 31. Global Small Molecule Drug CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Small Molecule Drug CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Small Molecule Drug CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Small Molecule Drug CDMO Market Share by Application (2019-2024)
Table 35. Global Small Molecule Drug CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Small Molecule Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Small Molecule Drug CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Small Molecule Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Small Molecule Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Small Molecule Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Small Molecule Drug CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Small Molecule Drug CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Lonza Small Molecule Drug CDMO Basic Information
Table 44. Lonza Small Molecule Drug CDMO Product Overview
Table 45. Lonza Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Small Molecule Drug CDMO SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. Catalent Small Molecule Drug CDMO Basic Information
Table 50. Catalent Small Molecule Drug CDMO Product Overview
Table 51. Catalent Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Catalent Business Overview
Table 53. Catalent Small Molecule Drug CDMO SWOT Analysis
Table 54. Catalent Recent Developments
Table 55. Thermo Fisher Scientific Small Molecule Drug CDMO Basic Information
Table 56. Thermo Fisher Scientific Small Molecule Drug CDMO Product Overview
Table 57. Thermo Fisher Scientific Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Small Molecule Drug CDMO SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Samsung Biologics Small Molecule Drug CDMO Basic Information
Table 62. Samsung Biologics Small Molecule Drug CDMO Product Overview
Table 63. Samsung Biologics Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Samsung Biologics Business Overview
Table 65. Samsung Biologics Recent Developments
Table 66. Fareva Small Molecule Drug CDMO Basic Information
Table 67. Fareva Small Molecule Drug CDMO Product Overview
Table 68. Fareva Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fareva Business Overview
Table 70. Fareva Recent Developments
Table 71. WuXi AppTech Small Molecule Drug CDMO Basic Information
Table 72. WuXi AppTech Small Molecule Drug CDMO Product Overview
Table 73. WuXi AppTech Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. WuXi AppTech Business Overview
Table 75. WuXi AppTech Recent Developments
Table 76. WuXi Biologics Small Molecule Drug CDMO Basic Information
Table 77. WuXi Biologics Small Molecule Drug CDMO Product Overview
Table 78. WuXi Biologics Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. WuXi Biologics Business Overview
Table 80. WuXi Biologics Recent Developments
Table 81. Siegfried Small Molecule Drug CDMO Basic Information
Table 82. Siegfried Small Molecule Drug CDMO Product Overview
Table 83. Siegfried Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Siegfried Business Overview
Table 85. Siegfried Recent Developments
Table 86. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Basic Information
Table 87. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Overview
Table 88. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. FUJIFILM Diosynth Biotechnologies Business Overview
Table 90. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 91. Asymchem Small Molecule Drug CDMO Basic Information
Table 92. Asymchem Small Molecule Drug CDMO Product Overview
Table 93. Asymchem Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Asymchem Business Overview
Table 95. Asymchem Recent Developments
Table 96. Pfizer CentreOne Small Molecule Drug CDMO Basic Information
Table 97. Pfizer CentreOne Small Molecule Drug CDMO Product Overview
Table 98. Pfizer CentreOne Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer CentreOne Business Overview
Table 100. Pfizer CentreOne Recent Developments
Table 101. Delpharm Small Molecule Drug CDMO Basic Information
Table 102. Delpharm Small Molecule Drug CDMO Product Overview
Table 103. Delpharm Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Delpharm Business Overview
Table 105. Delpharm Recent Developments
Table 106. Recipharm Small Molecule Drug CDMO Basic Information
Table 107. Recipharm Small Molecule Drug CDMO Product Overview
Table 108. Recipharm Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Recipharm Business Overview
Table 110. Recipharm Recent Developments
Table 111. AGC Pharma Chemicals Small Molecule Drug CDMO Basic Information
Table 112. AGC Pharma Chemicals Small Molecule Drug CDMO Product Overview
Table 113. AGC Pharma Chemicals Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. AGC Pharma Chemicals Business Overview
Table 115. AGC Pharma Chemicals Recent Developments
Table 116. Boehringer Ingelheim Small Molecule Drug CDMO Basic Information
Table 117. Boehringer Ingelheim Small Molecule Drug CDMO Product Overview
Table 118. Boehringer Ingelheim Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Boehringer Ingelheim Business Overview
Table 120. Boehringer Ingelheim Recent Developments
Table 121. Vetter Small Molecule Drug CDMO Basic Information
Table 122. Vetter Small Molecule Drug CDMO Product Overview
Table 123. Vetter Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Vetter Business Overview
Table 125. Vetter Recent Developments
Table 126. Curia Small Molecule Drug CDMO Basic Information
Table 127. Curia Small Molecule Drug CDMO Product Overview
Table 128. Curia Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Curia Business Overview
Table 130. Curia Recent Developments
Table 131. Aenova Small Molecule Drug CDMO Basic Information
Table 132. Aenova Small Molecule Drug CDMO Product Overview
Table 133. Aenova Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Aenova Business Overview
Table 135. Aenova Recent Developments
Table 136. Porton Small Molecule Drug CDMO Basic Information
Table 137. Porton Small Molecule Drug CDMO Product Overview
Table 138. Porton Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Porton Business Overview
Table 140. Porton Recent Developments
Table 141. Global Small Molecule Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 142. Global Small Molecule Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Small Molecule Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 144. North America Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Small Molecule Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 146. Europe Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Small Molecule Drug CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 148. Asia Pacific Small Molecule Drug CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Small Molecule Drug CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 150. South America Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Small Molecule Drug CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Small Molecule Drug CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Small Molecule Drug CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 154. Global Small Molecule Drug CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Small Molecule Drug CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 156. Global Small Molecule Drug CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 157. Global Small Molecule Drug CDMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Small Molecule Drug CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Drug CDMO Market Size (M USD), 2019-2030
Figure 5. Global Small Molecule Drug CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Small Molecule Drug CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Drug CDMO Market Size by Country (M USD)
Figure 11. Small Molecule Drug CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Small Molecule Drug CDMO Revenue Share by Manufacturers in 2023
Figure 13. Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Small Molecule Drug CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Small Molecule Drug CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Small Molecule Drug CDMO Market Share by Type
Figure 18. Sales Market Share of Small Molecule Drug CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Small Molecule Drug CDMO by Type in 2023
Figure 20. Market Size Share of Small Molecule Drug CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Small Molecule Drug CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Small Molecule Drug CDMO Market Share by Application
Figure 24. Global Small Molecule Drug CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Small Molecule Drug CDMO Sales Market Share by Application in 2023
Figure 26. Global Small Molecule Drug CDMO Market Share by Application (2019-2024)
Figure 27. Global Small Molecule Drug CDMO Market Share by Application in 2023
Figure 28. Global Small Molecule Drug CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Small Molecule Drug CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Small Molecule Drug CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Small Molecule Drug CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Small Molecule Drug CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Small Molecule Drug CDMO Sales Market Share by Country in 2023
Figure 37. Germany Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Small Molecule Drug CDMO Sales Market Share by Region in 2023
Figure 44. China Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 50. South America Small Molecule Drug CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Small Molecule Drug CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Small Molecule Drug CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Small Molecule Drug CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Small Molecule Drug CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Small Molecule Drug CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Small Molecule Drug CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Small Molecule Drug CDMO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Small Molecule Drug CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Drug CDMO Market Size (M USD), 2019-2030
Figure 5. Global Small Molecule Drug CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Small Molecule Drug CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Drug CDMO Market Size by Country (M USD)
Figure 11. Small Molecule Drug CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Small Molecule Drug CDMO Revenue Share by Manufacturers in 2023
Figure 13. Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Small Molecule Drug CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Small Molecule Drug CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Small Molecule Drug CDMO Market Share by Type
Figure 18. Sales Market Share of Small Molecule Drug CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Small Molecule Drug CDMO by Type in 2023
Figure 20. Market Size Share of Small Molecule Drug CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Small Molecule Drug CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Small Molecule Drug CDMO Market Share by Application
Figure 24. Global Small Molecule Drug CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Small Molecule Drug CDMO Sales Market Share by Application in 2023
Figure 26. Global Small Molecule Drug CDMO Market Share by Application (2019-2024)
Figure 27. Global Small Molecule Drug CDMO Market Share by Application in 2023
Figure 28. Global Small Molecule Drug CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Small Molecule Drug CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Small Molecule Drug CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Small Molecule Drug CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Small Molecule Drug CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Small Molecule Drug CDMO Sales Market Share by Country in 2023
Figure 37. Germany Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Small Molecule Drug CDMO Sales Market Share by Region in 2023
Figure 44. China Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 50. South America Small Molecule Drug CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Small Molecule Drug CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Small Molecule Drug CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Small Molecule Drug CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Small Molecule Drug CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Small Molecule Drug CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Small Molecule Drug CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Small Molecule Drug CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Small Molecule Drug CDMO Market Share Forecast by Application (2025-2030)
